ABIO
ARCA biopharma Inc
Halal Rating :
Last Price
$0.00
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Exchange
Next Earnings Date
ARCA biopharma, Inc. is a biopharmaceutical company focused on developing genetically targeted therapies for cardiovascular diseases. The company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator being developed for the treatment of atrial fibrillation in patients with heart failure.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate ARCA biopharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.